Detalhe da pesquisa
1.
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.
Lancet Oncol
; 25(2): 175-183, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218192
2.
[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study.
Eur J Nucl Med Mol Imaging
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467922
3.
Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study.
Eur J Nucl Med Mol Imaging
; 49(5): 1595-1606, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837103
4.
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers.
Eur J Nucl Med Mol Imaging
; 48(6): 1915-1931, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33244617
5.
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety.
Eur J Nucl Med Mol Imaging
; 47(4): 934-946, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707430
6.
Evaluation of [68Ga]Ga-DATA-TOC for imaging of neuroendocrine tumours: comparison with [68Ga]Ga-DOTA-NOC PET/CT.
Eur J Nucl Med Mol Imaging
; 47(4): 860-869, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754796
7.
Radioligand Therapy With 177Lu-PSMA for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.
AJR Am J Roentgenol
; 213(2): 275-285, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995089
8.
177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment.
Eur J Nucl Med Mol Imaging
; 44(1): 81-91, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27506431
9.
Evaluation of bone-seeking novel radiotracer 68Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast.
Eur J Nucl Med Mol Imaging
; 44(1): 41-49, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27455986
10.
A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 48(3): 942-944, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783111
11.
Reply to "Fact-Checking on 177Lu-PSMA Nephrotoxicity".
AJR Am J Roentgenol
; 215(1): W3-W4, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32568581
12.
An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients.
Indian J Med Res
; 139(4): 544-54, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927340
13.
Complete Response to 177 Lu-DOTATATE PRRT in a 9-Year-Old Child With Metastatic Carotid Body Paraganglioma.
Clin Nucl Med
; 49(1): e33-e34, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976428
14.
Promising Therapeutic Activity of 177 Lu-PSMA-617 in Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer : A Pilot Experience.
Clin Nucl Med
; 49(2): 131-137, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049970
15.
Head-to-Head Comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer.
Thyroid
; 33(8): 974-982, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171126
16.
Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics.
Cancers (Basel)
; 15(6)2023 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980775
17.
Reply to Rahbar K et al.
Eur J Nucl Med Mol Imaging
; 44(1): 168-169, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27695908
18.
Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients receiving Concomitant 225Ac-DOTATATE Targeted Alpha Therapy and Capecitabine: A Real-world Scenario Management Based Long-term Outcome Study.
J Nucl Med
; 2022 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863893
19.
First-in-Human Experience With 177Lu-DOTAGA.(SA.FAPi)2 Therapy in an Uncommon Case of Aggressive Medullary Thyroid Carcinoma Clinically Mimicking as Anaplastic Thyroid Cancer.
Clin Nucl Med
; 47(6): e444-e445, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507435
20.
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study.
Thyroid
; 32(1): 65-77, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34641705